ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.780,80
0,54%
S&P 500
5.217,00
0,06%
Dow Jones
39.456,90
0,18%
Euro vs US Dollar
1,07611
-0,19%
Bitcoin
60.860,05
-3,47%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Alexion Pharmaceuticals Inc (ALXN)

  7. Alexion Pharmaceuticals Inc (ALXN) News

ALXN

Alexion Pharmaceuticals (ALXN)

Alexion Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ALXN
DatumZeitQuelleÜberschriftSymbolFirma
28/07/202310h54KR Market News알렉시온, 화이자 유전자 치료제를 10억 달러 인수 합의NASDAQ:ALXNAlexion Pharmaceuticals Inc
28/07/202310h23KR Market News아스트라제네카, 항암제 수요로 2분기 결과 예상치 상회NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202115h09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h23Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h22Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h21Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ALXN

Kürzlich von Ihnen besucht

AMEX
SPY
SPDR S&P 500
DBI
MDAX
MDAX
TG
CBK
Commerzbank
DBI
TDXP
Tec DAX
TG
ALV
Allianz
NYSE
MRK
Merck
TG
LHA
Deutsche Lufthansa
DBI
SDXP
SDAX
TG
BAYN
Bayer
TG
RHM
Rheinmetall
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
TG
DTE
Deutsche Telekom
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten